{"id":"W4379336228","doi":"10.1200/jco.2023.41.16_suppl.e17630","title":"Treatment with lenvatinib plus pembrolizumab in recurrent or advanced endometrial cancer: A systematic review and meta-analysis.","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Lenvatinib; Internal medicine; Endometrial cancer; Oncology; Meta-analysis; Cancer; Immunotherapy; Thyroid cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01079302,0.002633441,0.01818763,0.007625769,0.0005346301,0.002834792,0.00202535,0.002179735,0.004098109],"category_scores_gemma":[0.0193104,0.001513881,0.03740923,0.008038973,0.0005934963,0.001851962,0.001503916,0.001604101,0.000441486],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00272763,"about_ca_system_score_gemma":0.003884487,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007443517,"about_ca_topic_score_gemma":0.01771037,"domain_scores_codex":[0.9932985,0.003232948,0.001887767,0.0006249953,0.0007300019,0.0002258309],"domain_scores_gemma":[0.9916642,0.005281888,0.001842566,0.0002649941,0.0007690472,0.0001774782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001697847,0.00002839863,0.001829745,0.402377,0.5822612,0.00009898381,0.00006270235,0.0004363516,0.0002069073,0.0001080474,0.0006028438,0.01029001],"study_design_scores_gemma":[0.0005997106,0.0001731716,0.002062488,0.02600603,0.9690502,0.00006802569,0.0000402914,0.0001673469,0.00008158226,0.0001415491,0.001589272,0.0000203201],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003150862,0.9950656,0.0004242356,0.0002027467,0.0001304939,0.0002995781,0.000483286,0.00002162501,0.0002216036],"genre_scores_gemma":[0.1380011,0.8556085,0.002294637,0.001082695,0.0002310596,0.001332414,0.0009772066,0.00003382265,0.000438576],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01818763,"threshold_uncertainty_score":0.05707961,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5084981135942951,"score_gpt":0.5814257263023181,"score_spread":0.07292761270802306,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}